Molecure S.a.
Clinical trials sponsored by Molecure S.a., explained in plain language.
Biotech developing small-molecule drugs for cancer and fibrosis.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a pill boost the immune system to fight Hard-to-Treat cancers?
Disease control Recruiting nowThis early-stage trial is testing an experimental oral drug called OATD-02 in people with advanced or metastatic colorectal, ovarian, pancreatic, or renal cell cancer. The goal is to see if the drug is safe and whether it can help the immune system attack tumors by increasing arg…
Phase: PHASE1 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New pill could tame lung inflammation in sarcoidosis
Disease control Recruiting nowThis Phase 2 trial tests OATD-01, an oral drug that blocks a protein called chitinase-1, in 96 people with active pulmonary sarcoidosis. Participants take the drug or a placebo for 12 weeks to see if it reduces lung inflammation measured by PET scans. The goal is to find a new tr…
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC